Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$50 BO with CVR attached
I certainly hope CVR’s are included if a buyout happens. Too many possible indications in the future that could be worth a fortune most notably IMO Alzheimer’s
I just can’t imagine if I was A management or board member reading the crap being made public by so called credible people. Time to go after them and make things right.
Sue Dr Nissen
Sue the Cleveland clinic
End of the day vascepa works !!!!!
This Dr who is supposedly well respected is spouting absolute non sense and it needs to be addressed IMO. It not only hurts amarin but many patients that could afford to be on vascepa
Enough is enough dealing with this crap
I sent an email to investor relations asking if they had any plans to fight back against Dr Nissen, I will let you know what they say if they respond
Per pharmacydude expect it to be completed and the data analyzed and ready to be made public by March
He is saying March could be the month we have the Covid data and european approval and ready to roll in Europe
Yes correct but from biobillionaires previous post he said could we potentially see a 2:1 deal with gild
I took that as 2 gild shares for 1 amarin, tm100 took it as the opposite
Btw bio just responded saying $200 a share so I think I read his response correctly
Ok maybe that’s what bio meant and I read that wrong
So what could you see in a buyout from GILD
Bio recently posted 2 gild shares for every 1 amarin, could you see the same???
I would love to be wrong but can’t see how the presentation on sat will be earth shattering. Phase 2 results with a small study. Just doesn’t add up for me. I do think this is a stepping stone to support the 2021 studies and that is the important part to take away. Saturday will be positive IMO and 2021 will be a much better year for Amarin and all of us
I agree that if the results next sat are positive that the drug will be used for Covid cases. I am trying to gauge at what point it could possibly be used as a widespread drug for Covid. My point with saying phase 2 and no is that won’t be enough to get the drug to that point. Would phase 3 results get us there in which we hear vascepa on news stations etc? A point where pharmacydude said genetics don’t matter because the demand will be more then the supply???
Thanks is the phase 3 results enough to get it on label or do we need to wait till phase 4 which is later in 2021
True so let me ask this, if results are very positive could phase 3 be skipped and they go off of these results? I am thinking no but others on this board more knowledgeable then me
Go back and read some posts by pharmacydude recently and that may help you. He strongly believes it will be positive. Since this is only phase 2 study may be reason for less urgency on the reporting part JMO
I figured as not one post about it and stock price stagnant
Thanks
It says today at 10 am eastern
K thanks and I agree
Did you mean can instead of can’t???
If you meant can’t I don’t follow your post
Obviously I agree with you
So you have China with possibly the reduce it label, Europe, 90% of US market and trials for colon cancer, Alzheimer’s etc etc etc and ultimate payout for some of you that you would be happy with is $15???
If Alzheimer’s trial is positive that would be like the holy grail. A friend of mine who is high up in a BP company said that would be the ultimate result
Again hear me out I am not saying let’s sit around 3 to 5 more years hoping for these type results but don’t sell the company on the cheap. Do something that if these type of trials are positive that we are rewarded.
Cvr’s probably are the answer
I have no problem if company is sold but not on the cheap. If we could get as zmanindc said somewhere in the $20’s for the company with cvr’s for future indications and US I would be completely fine with that
I would not be fine with $15 and that is it.
Where would stock price be in we didn’t get f’d by Judge du???
Stock price can turn on a dime and you know that. All I am saying is I don’t want them to sell on the cheap and IMO mid teens is the cheap
What do you consider young?
Ok I agree with that but cvr’s for those indications and for us??? That would make sense to me
Correct because the trial results are not known yet. If they are positive what will happen to the share price???
IMO company worth much more then mid teens. I don’t care about present stock price I care about future opportunities. Been in this too long to give it up on the cheap
If success of these trials could push the stock to $50 plus minimum and I have read more then once that there is a relatively decent chance on success with the Alzheimer’s study ( don’t remember anyone chiming in on success with colon cancer) why on earth would be want to sell for low teens.
Doesn’t make sense to me especially when we have so many other catalysts that could get us much higher then mid teens as has already been stated
If the reason is you are sick of waiting and have had enough of the stock then personally you should move on IMO. I have been here since 2011 and yes I would love it to happen now but not in the cards and 2 more years for me is okay to get the best payout
If success of these trials could push the stock to $50 plus minimum and I have read more then once that there is a relatively decent chance on success with the Alzheimer’s study ( don’t remember anyone chiming in on success with colon cancer) why on earth would be want to sell for low teens.
Doesn’t make sense to me especially when we have so many other catalysts that could get us much higher then mid teens as has already been stated
If the reason is you are sick of waiting and have had enough of the stock then personally you should move on IMO. I have been here since 2011 and yes I would love it to happen now but not in the cards and 2 more years for me is okay to get the best payout
Alot of the price targets are too low IMO. The US market is not lost. I agree with pharmacydude that we will be over our high of $26 mid 2021...
China, Europe, Covid, 90 plus % of us market is worth more then $18 a share and I believe a BP will eventually pay for that. How high I don’t know but could be $30 plus if not higher.
Bio billionaire says possibly $20 billion that is $47 a share.
I know many will say your crazy but I don’t think so.
Thanks and agree IMO we will all be happy with the final outcome, maybe not $100 a share but high enough to be rewarded for all we have been through
Well my point is that there is a good chance the trials will be successful and that only increases the value of amarin in a buyout. Not questioning you that BP could market the drug better but I find it odd when people on this board keep on saying give me $10, or we will be lucky to get $15
Doesn’t make much sense to me as the value of amarin especially if these trials pan out is much higher IMO
I agree just seems like no one is factoring that in. From what I have been reading seems like the trials have a very good chance of being successful
With Covid spiking up again why wouldn’t a successful trial showing vascepa helping Covid Patients not be a huge increase to share price???
So when vascepa is proven to help with Covid patients you still feel the company is worth a max of $15 a share???
Not even factoring Europe and ROW for the reduce it indication and outside chance on US market
My thought is if generics know they can’t sell
More then 5% of total sales without infringement they probably
Don’t enter the market at all and may result in a settlement
Or if they do enter certainly are limited to total sales. Maybe hard to keep them at 5% but if they reach 10% or more that won’t be hard to prove they are infringing
No i don’t think so was asking bio what his thoughts are with this
Okay thanks but the only way she makes appeals decision is if the case is remanded back to her correct???
Bio what does it mean that she signed the order?
Ok thanks that sounds doable